{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T09:02:04Z","timestamp":1790326924322,"version":"4.1.0"},"reference-count":107,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T00:00:00Z","timestamp":1790294400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pharmacol."],"abstract":"<jats:p>\n                    Hematologic malignancies are highly heterogeneous diseases in which the emergence of therapy resistance remains a major obstacle to durable clinical benefit. Cannabinoids, acting through the endocannabinoid system, have drawn increasing interest because of their potential to modulate multiple resistance-associated pathways, yet the available evidence remains fragmented across disease entities, experimental models, and mechanistic frameworks. In this narrative review, we examine the molecular mechanisms by which cannabinoids may counteract drug resistance in leukemia, lymphoma, and multiple myeloma. We discuss their effects on ABC transporter-mediated drug efflux, mitochondrial apoptosis, redox homeostasis, endoplasmic reticulum stress and autophagy, pro-survival signaling, and tumor microenvironment-mediated protection. We also evaluate preclinical evidence for cannabinoid-based combinations with conventional chemotherapy, targeted therapies, immunotherapies, and radiotherapy. Although\n                    <jats:italic>in vitro<\/jats:italic>\n                    and animal studies indicate that cannabinoids may reverse resistant phenotypes and enhance the activity of existing treatments, the translational relevance of these findings is limited by the predominance of cell-line and xenograft models, the paucity of clinical evidence for antitumor efficacy, pharmacokinetic constraints, potential drug\u2013drug interactions, and context-dependent effects that may be neutral or adverse in certain immunological settings. Thus, while the endocannabinoid system represents a potential therapeutic target for sensitizing resistant hematologic malignancies, clinical translation will require validation at pharmacologically achievable exposures, the use of immunocompetent and clinically relevant models, identification of predictive biomarkers, and rigorous evaluation in prospective clinical studies.\n                  <\/jats:p>","DOI":"10.3389\/fphar.2026.1921501","type":"journal-article","created":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T08:11:30Z","timestamp":1790323890000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Cannabinoids in hematologic malignancies: mechanisms and therapeutic potential for overcoming drug resistance"],"prefix":"10.3389","volume":"17","author":[{"given":"Sixu","family":"Li","sequence":"first","affiliation":[{"name":"College of Food Science and Technology, Shanghai Ocean University","place":["Shanghai, China"]},{"name":"Navy Medical Center, Naval Medical University","place":["Shanghai, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaokun","family":"Jian","sequence":"additional","affiliation":[{"name":"College of Food Science and Technology, Shanghai Ocean University","place":["Shanghai, China"]},{"name":"Navy Medical Center, Naval Medical University","place":["Shanghai, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yufu","family":"Tang","sequence":"additional","affiliation":[{"name":"Navy Medical Center, Naval Medical University","place":["Shanghai, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhentao","family":"Wang","sequence":"additional","affiliation":[{"name":"Navy Medical Center, Naval Medical University","place":["Shanghai, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tianjiao","family":"Min","sequence":"additional","affiliation":[{"name":"Navy Medical Center, Naval Medical University","place":["Shanghai, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luyao","family":"Yu","sequence":"additional","affiliation":[{"name":"Navy Medical Center, Naval Medical University","place":["Shanghai, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beier","family":"Jiang","sequence":"additional","affiliation":[{"name":"Navy Medical Center, Naval Medical University","place":["Shanghai, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"He","sequence":"additional","affiliation":[{"name":"Navy Medical Center, Naval Medical University","place":["Shanghai, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,9,25]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"4594","DOI":"10.1182\/blood-2002-01-0271","article-title":"Low levels of ABCG2 expression in adult AML blast samples","volume":"100","author":"Abbott","year":"2002","journal-title":"Blood"},{"key":"B2","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1002\/cpt.108","article-title":"Cannabis in cancer care","volume":"97","author":"Abrams","year":"2015","journal-title":"Clin Pharma Ther."},{"key":"B3","doi-asserted-by":"publisher","first-page":"1208","DOI":"10.1002\/biof.2078","article-title":"Anticancer effect of minor phytocannabinoids in preclinical models of multiple myeloma","volume":"50","author":"Aguzzi","year":"2024","journal-title":"BioFactors"},{"key":"B4","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1186\/s42238-025-00289-5","article-title":"Revealing the therapeutic potential of synthetic cannabinoids: a systematic review of cannabinoid receptor binding dynamics and their implications for cancer therapy","volume":"7","author":"Alghamdi","year":"2025","journal-title":"J. Cannabis Res."},{"key":"B5","doi-asserted-by":"publisher","first-page":"914","DOI":"10.1002\/ptr.7357","article-title":"Chemical characterization of non-psychoactive Cannabis sativa L. extracts, in vitro antiproliferative activity and induction of apoptosis in chronic myelogenous leukaemia cancer cells","volume":"36","author":"Anceschi","year":"2022","journal-title":"Phytother. Res."},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.5281\/ZENODO.14584921","article-title":"A comprehensive review of cannabis sativa: history","author":"Ankit Singh","year":"2025","journal-title":"Chemistry, Anticancer Properties"},{"key":"B7","doi-asserted-by":"publisher","first-page":"1997","DOI":"10.1007\/s12672-025-03814-3","article-title":"Harnessing the power of exosomes in leukemia: from molecular messengers to clinical applications","volume":"16","author":"Ansarian","year":"2025","journal-title":"Discov. Oncol."},{"key":"B8","doi-asserted-by":"publisher","first-page":"751","DOI":"10.1016\/S1734-1140(12)70871-X","article-title":"CB2 and TRPV1 receptors mediate cannabinoid actions on MDR1 expression in multidrug resistant cells","volume":"64","author":"Arnold","year":"2012","journal-title":"Pharmacol. Rep."},{"key":"B9","doi-asserted-by":"publisher","first-page":"6091","DOI":"10.3390\/ijms21176091","article-title":"Drug resistance in hematological malignancies","volume":"21","author":"Auberger","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"B10","doi-asserted-by":"publisher","first-page":"213","DOI":"10.64062\/JPGMB.Vol1.Issue4.18","article-title":"Role of cannabinoids in chronic pain management: a pharmacodynamic perspective","author":"Banchhor","year":"2025","journal-title":"J. Pharmacol. Genet. Mol. Biol."},{"key":"B11","doi-asserted-by":"publisher","first-page":"2447","DOI":"10.3390\/cancers14081957","article-title":"Correction: bar-sela et al. Cannabis consumption used by cancer patients during immunotherapy correlates with poor clinical outcome","volume":"12","author":"Bar-Sela","year":"2022","journal-title":"Cancers"},{"key":"B12","doi-asserted-by":"publisher","first-page":"RP90854","DOI":"10.7554\/eLife.90854","article-title":"Cannabinoid combination targets NOTCH1-mutated T-cell acute lymphoblastic leukemia through the integrated stress response pathway","volume":"12","author":"Besser","year":"2024","journal-title":"eLife"},{"key":"B13","doi-asserted-by":"publisher","first-page":"872","DOI":"10.1016\/j.ccell.2020.10.010","article-title":"Reduced mitochondrial apoptotic priming drives resistance to BH3 mimetics in acute myeloid leukemia","volume":"38","author":"Bhatt","year":"2020","journal-title":"Cancer Cell"},{"key":"B14","doi-asserted-by":"publisher","first-page":"45","DOI":"10.3390\/ijms26010045","article-title":"Unlocking the heterogeneity in acute leukaemia: dissection of clonal architecture and metabolic properties for clinical interventions","volume":"26","author":"Capelletti","year":"2024","journal-title":"Int. J. Mol. Sci."},{"key":"B15","doi-asserted-by":"publisher","first-page":"e24196","DOI":"10.1016\/j.heliyon.2024.e24196","article-title":"A label free chemoproteomic-based platform to disclose cannabidiol molecular mechanism of action on chronic myelogenous leukemia cancer cells","volume":"10","author":"Ceccacci","year":"2024","journal-title":"Heliyon"},{"key":"B16","doi-asserted-by":"publisher","first-page":"819","DOI":"10.1089\/can.2023.0108","article-title":"Effects of cannabidiol on the functions of chimeric antigen receptor T cells in hematologic malignancies","volume":"9","author":"Chantarat","year":"2024","journal-title":"Cannabis Cannabinoid Res."},{"key":"B17","doi-asserted-by":"publisher","first-page":"e1593","DOI":"10.1038\/cddis.2014.525","article-title":"MCL-1 and BCL-xL-dependent resistance to the BCL-2 inhibitor ABT-199 can be overcome by preventing PI3K\/AKT\/mTOR activation in lymphoid malignancies","volume":"6","author":"Choudhary","year":"2015","journal-title":"Cell Death Dis."},{"key":"B18","doi-asserted-by":"publisher","first-page":"11157","DOI":"10.3390\/ijms262211157","article-title":"Targeting multidrug resistance in cancer: impact of retinoids, rexinoids, and carotenoids on ABC transporters","volume":"26","author":"\u010ci\u017em\u00e1rikov\u00e1","year":"2025","journal-title":"Int. J. Mol. Sci."},{"key":"B19","doi-asserted-by":"publisher","first-page":"10692","DOI":"10.1096\/fj.201900140R","article-title":"Structure\u2010guided probing of the leukotriene C4 binding site in human multidrug resistance protein 1 (MRP1; ABCC1)","volume":"33","author":"Conseil","year":"2019","journal-title":"FASEB J."},{"key":"B20","volume-title":"The Human ATP-Binding Cassette (ABC) Transporter Superfamily","author":"Dean","year":"2002"},{"key":"B21","doi-asserted-by":"publisher","first-page":"1386548","DOI":"10.3389\/fimmu.2024.1386548","article-title":"Cannabinoids and triple-negative breast cancer treatment","volume":"15","author":"Dobovi\u0161ek","year":"2024","journal-title":"Front. Immunol."},{"key":"B22","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1016\/j.ejca.2012.05.005","article-title":"A review on CXCR4\/CXCL12 axis in oncology: no place to hide","volume":"49","author":"Domanska","year":"2013","journal-title":"Eur. J. Cancer"},{"key":"B23","doi-asserted-by":"publisher","first-page":"100094","DOI":"10.1016\/j.gmg.2026.100094","article-title":"Cannabidiol modulates exosomal miRNA networks to enhance imatinib mesylate response in chronic myelogenous leukemia","volume":"13","author":"Donchev","year":"2026","journal-title":"Glob. Med. Genet."},{"key":"B24","doi-asserted-by":"publisher","first-page":"5709","DOI":"10.1038\/s41467-023-41229-2","article-title":"ABCC1 and glutathione metabolism limit the efficacy of BCL-2 inhibitors in acute myeloid leukemia","volume":"14","author":"Ebner","year":"2023","journal-title":"Nat. Commun."},{"key":"B25","doi-asserted-by":"publisher","first-page":"1796","DOI":"10.1002\/mc.22251","article-title":"Targeting cannabinoid receptor-2 pathway by phenylacetylamide suppresses the proliferation of human myeloma cells through mitotic dysregulation and cytoskeleton disruption","volume":"54","author":"Feng","year":"2015","journal-title":"Mol. Carcinog."},{"key":"B26","doi-asserted-by":"publisher","first-page":"113116","DOI":"10.1016\/j.ejmech.2020.113116","article-title":"Variously substituted 2-oxopyridine derivatives: extending the structure-activity relationships for allosteric modulation of the cannabinoid CB2 receptor","volume":"211","author":"Gado","year":"2021","journal-title":"Eur. J. Med. Chem."},{"key":"B27","doi-asserted-by":"publisher","first-page":"1767","DOI":"10.1080\/1042819031000103917","article-title":"\u03b3-irradiation enhances apoptosis induced by cannabidiol, a non-psychotropic cannabinoid, in cultured HL-60 myeloblastic leukemia cells","volume":"44","author":"Gallily","year":"2003","journal-title":"Leuk. Lymphoma"},{"key":"B28","doi-asserted-by":"publisher","first-page":"3800","DOI":"10.3390\/ijms21113800","article-title":"High expression of cannabinoid receptor 2 on cytokine-induced killer cells and multiple myeloma cells","volume":"21","author":"Garofano","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"B29","doi-asserted-by":"publisher","first-page":"2430","DOI":"10.1038\/s41375-020-0756-6","article-title":"Integrated safety profile of selinexor in multiple myeloma: experience from 437 patients enrolled in clinical trials","volume":"34","author":"Gavriatopoulou","year":"2020","journal-title":"Leukemia"},{"key":"B30","doi-asserted-by":"publisher","first-page":"1612","DOI":"10.1124\/mol.106.025981","article-title":"Cannabinoid receptor-mediated apoptosis induced by R(+)-methanandamide and Win55,212-2 is associated with ceramide accumulation and p38 activation in mantle cell lymphoma","volume":"70","author":"Gustafsson","year":"2006","journal-title":"Mol. Pharmacol."},{"key":"B31","doi-asserted-by":"publisher","first-page":"1","DOI":"10.4172\/1948-5956.1000508","article-title":"The association between cancer and ABC transporters","volume":"10","author":"Hassanpour","year":"2017","journal-title":"J. Cancer Sci. Ther."},{"key":"B32","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1038\/nm.4040","article-title":"Tumor cells can follow distinct evolutionary paths to become resistant to epidermal growth factor receptor inhibition","volume":"22","author":"Hata","year":"2016","journal-title":"Nat. Med."},{"key":"B33","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1124\/mol.108.047035","article-title":"Attenuation of experimental autoimmune hepatitis by exogenous and endogenous cannabinoids: involvement of regulatory T cells","volume":"74","author":"Hegde","year":"2008","journal-title":"Mol. Pharmacol."},{"key":"B34","doi-asserted-by":"publisher","first-page":"588","DOI":"10.1097\/QAI.0000000000001449","article-title":"\u03949-tetrahydrocannabinol suppresses secretion of IFN\u03b1 by plasmacytoid dendritic cells from healthy and HIV-Infected individuals","volume":"75","author":"Henriquez","year":"2017","journal-title":"JAIDS J. Acquir. Immune Defic. Syndr."},{"key":"B35","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1186\/s42238-025-00294-8","article-title":"Enhancing cannabinoid bioavailability: a crossover study comparing a novel self-nanoemulsifying drug delivery system and a commercial oil-based formulation","volume":"7","author":"Hermush","year":"2025","journal-title":"J. Cannabis Res."},{"key":"B36","doi-asserted-by":"publisher","first-page":"2121","DOI":"10.1016\/j.yexcr.2006.03.009","article-title":"The CB2 cannabinoid receptor signals apoptosis via ceramide-dependent activation of the mitochondrial intrinsic pathway","volume":"312","author":"Herrera","year":"2006","journal-title":"Exp. Cell Res."},{"key":"B107","doi-asserted-by":"publisher","first-page":"16639","DOI":"10.1074\/jbc.M200360200","article-title":"NF-\u03baB as a therapeutic target in multiple myeloma","volume":"277","author":"Hideshima","year":"2002","journal-title":"J. Biol. Chem."},{"key":"B37","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41416-022-01727-4","article-title":"Cannabinoids as anticancer drugs: current status of preclinical research","volume":"127","author":"Hinz","year":"2022","journal-title":"Br. J. Cancer"},{"key":"B38","doi-asserted-by":"publisher","first-page":"1146","DOI":"10.1016\/j.bcp.2005.12.033","article-title":"The effects of cannabinoids on P-glycoprotein transport and expression in multidrug resistant cells","volume":"71","author":"Holland","year":"2006","journal-title":"Biochem. Pharmacol."},{"key":"B39","doi-asserted-by":"publisher","first-page":"815","DOI":"10.1038\/sj.bjp.0707467","article-title":"The multidrug transporter ABCG2 (BCRP) is inhibited by plant-derived cannabinoids","volume":"152","author":"Holland","year":"2007","journal-title":"Br. J. Pharmacol."},{"key":"B40","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1016\/j.ejphar.2008.06.079","article-title":"Interaction of plant cannabinoids with the multidrug transporter ABCC1 (MRP1)","volume":"591","author":"Holland","year":"2008","journal-title":"Eur. J. Pharmacol."},{"key":"B41","volume-title":"Pharmacogenetics of Chemotherapy Treatment Response and -toxicities in Patients with Osteosarcoma: A Systematic Review of 2010-2020","author":"Hurkmans","year":"2022"},{"key":"B42","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1089\/can.2016.0034","article-title":"An update on safety and side effects of cannabidiol: a review of clinical data and relevant animal studies","volume":"2","author":"Iffland","year":"2017","journal-title":"Cannabis Cannabinoid Res."},{"key":"B43","first-page":"1","volume-title":"Treatment of Cannabidiol, \u03b3-radiation and Small Molecule Inhibitors","author":"Ivanov","year":"2017"},{"key":"B44","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1038\/onc.2012.48","article-title":"Clonal evolution of acute leukemia genomes","volume":"32","author":"Jan","year":"2013","journal-title":"Oncogene"},{"key":"B45","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1158\/1541-7786.MCR-05-0193","article-title":"\u03949-tetrahydrocannabinol-induced apoptosis in jurkat leukemia T cells is regulated by translocation of bad to mitochondria","volume":"4","author":"Jia","year":"2006","journal-title":"Mol. Cancer Res."},{"key":"B46","doi-asserted-by":"publisher","first-page":"5970","DOI":"10.3390\/molecules29245970","article-title":"The anticancer activity of cannabinol (CBN) and cannabigerol (CBG) on acute myeloid leukemia cells","volume":"29","author":"Kadriya","year":"2024","journal-title":"Molecules"},{"key":"B47","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fphar.2017.00144","article-title":"Cannabidiol reduces leukemic cell size \u2013 but is it important?","volume":"8","author":"Kalenderoglou","year":"2017","journal-title":"Front. Pharmacol."},{"key":"B48","doi-asserted-by":"publisher","first-page":"1796","DOI":"10.1158\/2326-6066.CIR-23-0902","article-title":"Cannabidiol enhances atezolizumab efficacy by upregulating PD-L1 expression via the cGAS\u2013STING pathway in triple-negative breast cancer cells","volume":"12","author":"Kim","year":"2024","journal-title":"Cancer Immunol. Res."},{"key":"B49","doi-asserted-by":"publisher","first-page":"29","DOI":"10.2217\/14622416.8.1.29","article-title":"Ethnicity-related polymorphisms and haplotypes in the human ABCB1 gene","volume":"8","author":"Kimchi-Sarfaty","year":"2007","journal-title":"Pharmacogenomics"},{"key":"B50","doi-asserted-by":"publisher","first-page":"1","DOI":"10.5604\/01.3001.0054.7061","article-title":"The potential role of CAR-T in multiple myeloma treatment. A review","volume":"18","author":"Kostelecka","year":"2024","journal-title":"Med. Sci. Pulse"},{"key":"B51","doi-asserted-by":"publisher","first-page":"e0298697","DOI":"10.1371\/journal.pone.0298697","article-title":"THC and sperm: impact on fertilization capability, pre-implantation in vitro development and epigenetic modifications","volume":"19","author":"Kuzma-Hunt","year":"2024","journal-title":"PLOS One"},{"key":"B52","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1038\/leu.2013.248","article-title":"Clonal evolution in hematological malignancies and therapeutic implications","volume":"28","author":"Landau","year":"2014","journal-title":"Leukemia"},{"key":"B53","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1186\/s44424-026-00052-4","article-title":"Phytocannabinoids in central nervous system disorders and frameworks for cellular stress adaptation: a comprehensive review","volume":"19","author":"Lee","year":"2026","journal-title":"Innov. Acupunct. Med."},{"key":"B54","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/clinbioenerg2010001","article-title":"Therapy-induced mitochondrial dysfunction and metabolic plasticity in myeloid malignancies","volume":"2","author":"Lee","year":"2026","journal-title":"Clin. Bioenerg."},{"key":"B55","doi-asserted-by":"publisher","first-page":"1800","DOI":"10.1080\/10428190802239188","article-title":"Enhancing the in vitro cytotoxic activity of \u03949 -tetrahydrocannabinol in leukemic cells through a combinatorial approach","volume":"49","author":"Liu","year":"2008","journal-title":"Leuk. Lymphoma"},{"key":"B56","doi-asserted-by":"publisher","first-page":"959","DOI":"10.1038\/cdd.2010.170","article-title":"Stimulation of the midkine\/ALK axis renders glioma cells resistant to cannabinoid antitumoral action","volume":"18","author":"Lorente","year":"2011","journal-title":"Cell Death Differ."},{"key":"B57","doi-asserted-by":"publisher","first-page":"1235","DOI":"10.1111\/cas.15257","article-title":"The effects of cannabidiol via TRPV2 channel in chronic myeloid leukemia cells and its combination with imatinib","volume":"113","author":"Maggi","year":"2022","journal-title":"Cancer Sci."},{"key":"B58","doi-asserted-by":"publisher","first-page":"1785587","DOI":"10.3389\/fimmu.2026.1785587","article-title":"From immune exclusion to exhaustion: tumor microenvironment drives therapy response","volume":"17","author":"Maletin","year":"2026","journal-title":"Front. Immunol."},{"key":"B59","doi-asserted-by":"publisher","first-page":"100774","DOI":"10.1016\/j.jbior.2020.100774","article-title":"Therapeutic potential of cannabinoids in combination cancer therapy","volume":"79","author":"Malhotra","year":"2021","journal-title":"Adv. Biol. Regul."},{"key":"B60","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1111\/j.1365-2125.2012.04298.x","article-title":"Cannabidiol as potential anticancer drug","volume":"75","author":"Massi","year":"2013","journal-title":"Br. J. Clin. Pharmacol."},{"key":"B61","doi-asserted-by":"publisher","first-page":"897","DOI":"10.1124\/mol.106.023937","article-title":"Cannabidiol-induced apoptosis in human leukemia cells: a novel role of cannabidiol in the regulation of p22 and Nox4 expression","volume":"70","author":"McKallip","year":"2006","journal-title":"Mol. Pharmacol."},{"key":"B62","doi-asserted-by":"publisher","first-page":"1529","DOI":"10.1038\/s41416-024-02618-6","article-title":"Cannabinoids induce cell death in leukaemic cells through parthanatos and PARP-related metabolic disruptions","volume":"130","author":"Medrano","year":"2024","journal-title":"Br. J. Cancer"},{"key":"B63","doi-asserted-by":"publisher","first-page":"1585","DOI":"10.3390\/cancers15051585","article-title":"2-arachidonoylglycerol modulates CXCL12-mediated chemotaxis in mantle cell lymphoma and chronic lymphocytic leukemia","volume":"15","author":"Merrien","year":"2023","journal-title":"Cancers"},{"key":"B64","doi-asserted-by":"publisher","first-page":"4058","DOI":"10.3390\/ijms21114058","article-title":"Homology modeling of the human P-glycoprotein (ABCB1) and insights into ligand binding through molecular docking studies","volume":"21","author":"Mora Lagares","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"B65","doi-asserted-by":"publisher","first-page":"2534","DOI":"10.1002\/ijc.28591","article-title":"The effects of cannabidiol and its synergism with bortezomib in multiple myeloma cell lines. A role for transient receptor potential vanilloid type-2","volume":"134","author":"Morelli","year":"2014","journal-title":"Int. J. Cancer"},{"key":"B66","doi-asserted-by":"publisher","first-page":"630107","DOI":"10.3389\/fmolb.2021.630107","article-title":"Cannabidiol modulates mitochondrial redox and dynamics in MCF7 cancer cells: a study using fluorescence lifetime imaging microscopy of NAD(P)H","volume":"8","author":"Mould","year":"2021","journal-title":"Front. Mol. Biosci."},{"key":"B67","doi-asserted-by":"publisher","first-page":"1818501","DOI":"10.3389\/fphar.2026.1818501","article-title":"Cellular pharmacology of fludarabine: molecular determinants of transport and metabolism","volume":"17","author":"Mseddi","year":"2026","journal-title":"Front. Pharmacol."},{"key":"B68","doi-asserted-by":"publisher","first-page":"77543","DOI":"10.18632\/oncotarget.12721","article-title":"Cannabinoids synergize with carfilzomib, reducing multiple myeloma cells viability and migration","volume":"7","author":"Nabissi","year":"2016","journal-title":"Oncotarget"},{"key":"B69","doi-asserted-by":"publisher","first-page":"779","DOI":"10.1038\/s41419-019-2024-0","article-title":"Cannabidiol directly targets mitochondria and disturbs calcium homeostasis in acute lymphoblastic leukemia","volume":"10","author":"Olivas-Aguirre","year":"2019","journal-title":"Cell Death Dis."},{"key":"B70","doi-asserted-by":"publisher","first-page":"445","DOI":"10.3390\/cancers15020445","article-title":"Dexamethasone-induced fatty acid oxidation and autophagy\/mitophagy are essential for T-ALL glucocorticoid resistance","volume":"15","author":"Olivas-Aguirre","year":"2023","journal-title":"Cancers"},{"key":"B71","doi-asserted-by":"publisher","first-page":"122","DOI":"10.3390\/receptors3020007","article-title":"Molecular targets for cannabinoids in natural killer cells: do they modulate the antitumor activity?","volume":"3","author":"Olivas-Aguirre","year":"2024","journal-title":"Receptors"},{"key":"B72","doi-asserted-by":"publisher","first-page":"3","DOI":"10.3390\/biomedicines14010003","article-title":"Cytotoxicity of cannabinoids in combination with traditional lymphoma chemotherapeutic drugs against non-hodgkin\u2019s lymphoma","volume":"14","author":"Omer","year":"2025","journal-title":"Biomedicines"},{"key":"B73","doi-asserted-by":"publisher","first-page":"1041833","DOI":"10.3389\/fphys.2022.1041833","article-title":"Effects of cannabinoids on ligand-gated ion channels","volume":"13","author":"Oz","year":"2022","journal-title":"Front. Physiol."},{"key":"B74","doi-asserted-by":"publisher","first-page":"NS20200080","DOI":"10.1042\/NS20200080","article-title":"Cannabidiol modulation of oxidative stress and signalling","volume":"5","author":"Pereira","year":"2021","journal-title":"Neuronal Signal."},{"key":"B75","doi-asserted-by":"publisher","first-page":"1258","DOI":"10.1007\/s10637-014-0147-9","article-title":"An open-label study to determine the maximum tolerated dose of the multitargeted tyrosine kinase inhibitor CEP-11981 in patients with advanced cancer","volume":"32","author":"Pili","year":"2014","journal-title":"Invest. New Drugs"},{"key":"B76","doi-asserted-by":"publisher","first-page":"1214","DOI":"10.1182\/blood-2004-03-1182","article-title":"Cannabis-induced cytotoxicity in leukemic cell lines: the role of the cannabinoid receptors and the MAPK pathway","volume":"105","author":"Powles","year":"2005","journal-title":"Blood"},{"key":"B77","doi-asserted-by":"publisher","first-page":"5573","DOI":"10.1007\/s00277-025-06710-6","article-title":"Phytochemicals in overcoming venetoclax resistance in acute myeloid leukemia: mechanistic insights and therapeutic potential","volume":"104","author":"Prajapati","year":"2025","journal-title":"Ann. Hematol."},{"key":"B78","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1192\/bjb.2025.10183","article-title":"Questioning assumptions about the abuse potential of medical cannabis and cannabinoids: narrative review and commentary","volume":"50","author":"Pressman","year":"2026","journal-title":"BJPsych Bull."},{"key":"B79","doi-asserted-by":"publisher","first-page":"1217","DOI":"10.2174\/0929867053764617","article-title":"Targeting the cannabinoid CB2 receptor: mutations, modeling and development of CB2 selective ligands","volume":"12","author":"Raitio","year":"2005","journal-title":"Curr. Med. Chem."},{"key":"B80","doi-asserted-by":"publisher","first-page":"108851","DOI":"10.1016\/j.pharmthera.2025.108851","article-title":"Effect of cannabinoids on the efficacy and side effects of anticancer therapeutic strategies \u2013 current status of preclinical and clinical research","volume":"270","author":"Ramer","year":"2025","journal-title":"Pharmacol. Ther."},{"key":"B81","doi-asserted-by":"publisher","first-page":"598","DOI":"10.1016\/j.imbio.2009.04.001","article-title":"Cannabinoid-induced apoptosis in immune cells as a pathway to immunosuppression","volume":"215","author":"Rieder","year":"2010","journal-title":"Immunobiology"},{"key":"B82","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1124\/mol.105.019117","article-title":"Interleukin-2 suppression by 2-arachidonyl glycerol is mediated through peroxisome proliferator-activated receptor \u03b3 independently of cannabinoid receptors 1 and 2","volume":"70","author":"Rockwell","year":"2006","journal-title":"Mol. Pharmacol."},{"key":"B83","doi-asserted-by":"crossref","DOI":"10.34172\/PS.026.42859","volume-title":"A Folic acid-modified Polymeric Nanoliposome for tumor-targeted Drug Delivery","author":"Sadrykia","year":"2026"},{"key":"B84","doi-asserted-by":"publisher","first-page":"1359","DOI":"10.1172\/JCI37948","article-title":"Cannabinoid action induces autophagy-mediated cell death through stimulation of ER stress in human glioma cells","volume":"119","author":"Salazar","year":"2009","journal-title":"J. Clin. Invest."},{"key":"B85","doi-asserted-by":"publisher","first-page":"1","DOI":"10.4081\/hr.2017.7406","article-title":"Expression of some ATP-binding cassette transporters in acute myeloid leukemia","volume":"9","author":"Salvia","year":"2017","journal-title":"Hematol. Rep."},{"key":"B86","doi-asserted-by":"publisher","first-page":"3018","DOI":"10.1021\/acs.jmedchem.5b01644","article-title":"Pyrrolopyrimidine derivatives as novel inhibitors of multidrug resistance-associated protein 1 (MRP1, ABCC1)","volume":"59","author":"Schmitt","year":"2016","journal-title":"J. Med. Chem."},{"key":"B87","doi-asserted-by":"publisher","first-page":"2955","DOI":"10.1158\/1535-7163.MCT-14-0402","article-title":"The combination of cannabidiol and \u03949-tetrahydrocannabinol enhances the anticancer effects of radiation in an orthotopic murine glioma model","volume":"13","author":"Scott","year":"2014","journal-title":"Mol. Cancer Ther."},{"key":"B88","doi-asserted-by":"publisher","first-page":"369","DOI":"10.3892\/ijo.2017.4022","article-title":"Anticancer effects of phytocannabinoids used with chemotherapy in leukaemia cells can be improved by altering the sequence of their administration","volume":"51","author":"Scott","year":"2017","journal-title":"Int. J. Oncol."},{"key":"B89","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1007\/s10238-025-01713-z","article-title":"Impact of proteostasis workload on sensitivity to proteasome inhibitors in multiple myeloma","volume":"25","author":"Sedlacek","year":"2025","journal-title":"Clin. Exp. Med."},{"key":"B90","first-page":"1","volume-title":"Advances in Targeted Therapy: A New Era in Cancer Treatment","author":"Shane","year":"2024"},{"key":"B91","doi-asserted-by":"publisher","first-page":"11308","DOI":"10.1038\/s41467-025-66451-y","article-title":"Engineering HLA-G-targeted extracellular vesicles nanoplatform for enhanced cancer therapy through precise cancer drug delivery","volume":"16","author":"Shie","year":"2025","journal-title":"Nat. Commun."},{"key":"B92","doi-asserted-by":"publisher","first-page":"2052","DOI":"10.30574\/wjarr.2024.24.3.3876","article-title":"Cancer diagnosis and prognosis using multi-omics data: a data science and machine learning approach","volume":"24","author":"Shittu","year":"2024","journal-title":"World J. Adv. Res. Rev."},{"key":"B93","doi-asserted-by":"publisher","first-page":"2673","DOI":"10.1182\/blood-2024-208773","article-title":"Mutagenic DNA lesions in normal hematopoietic stem cells persist for years causing distinct patterns of mutation","volume":"144","author":"Spencer Chapman","year":"2024","journal-title":"Blood"},{"key":"B94","doi-asserted-by":"publisher","first-page":"8758","DOI":"10.1021\/acs.jmedchem.7b00788","article-title":"9-deazapurines as broad-spectrum inhibitors of the ABC transport proteins P-glycoprotein, multidrug resistance-associated protein 1, and breast cancer resistance protein","volume":"60","author":"Stefan","year":"2017","journal-title":"J. Med. Chem."},{"key":"B95","doi-asserted-by":"publisher","first-page":"5382","DOI":"10.1182\/blood-2018-99-116749","article-title":"Synergistic effect of cannabidiol with conventional chemotherapy treatment","volume":"132","author":"Strong","year":"2018","journal-title":"Blood"},{"key":"B96","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1634\/theoncologist.2018-0383","article-title":"Cannabis impacts tumor response rate to nivolumab in patients with advanced malignancies","volume":"24","author":"Taha","year":"2019","journal-title":"Oncologist"},{"key":"B97","doi-asserted-by":"publisher","first-page":"504","DOI":"10.1038\/nature22345","article-title":"Structure of the human multidrug transporter ABCG2","volume":"546","author":"Taylor","year":"2017","journal-title":"Nature"},{"key":"B98","doi-asserted-by":"publisher","first-page":"286","DOI":"10.3390\/antiox15030286","article-title":"THC and CBD induce heme oxygenase-1-dependent cell death and trigger mitochondrial dysfunction in human melanoma and cutaneous squamous cell carcinoma cells","volume":"15","author":"Thamm","year":"2026","journal-title":"Antioxidants"},{"key":"B99","doi-asserted-by":"publisher","first-page":"761","DOI":"10.1038\/leu.2015.184","article-title":"BH3 profiling identifies heterogeneous dependency on bcl-2 family members in multiple myeloma and predicts sensitivity to BH3 mimetics","volume":"30","author":"Touzeau","year":"2016","journal-title":"Leukemia"},{"key":"B100","doi-asserted-by":"publisher","DOI":"10.2903\/j.efsa.2022.7322","article-title":"Statement on safety of cannabidiol as a novel food: data gaps and uncertainties","volume":"20","author":"Turck","year":"2022","journal-title":"EFSA J."},{"key":"B101","doi-asserted-by":"publisher","first-page":"63","DOI":"10.21037\/atm-23-1824","article-title":"Remodeling of the bone marrow microenvironment during acute myeloid leukemia progression","volume":"12","author":"Urs","year":"2024","journal-title":"Ann. Transl. Med."},{"key":"B102","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1111\/jcmm.16110","article-title":"miR-15a-5p and miR-21-5p contribute to chemoresistance in cytogenetically normal acute myeloid leukaemia by targeting PDCD4, ARL2 and BTG2","volume":"25","author":"Vandewalle","year":"2021","journal-title":"J. Cell. Mol. Med."},{"key":"B103","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1038\/s41419-023-05919-5","article-title":"Diacylglycerol lipase alpha promotes hepatocellular carcinoma progression and induces lenvatinib resistance by enhancing YAP activity","volume":"14","author":"Yan","year":"2023","journal-title":"Cell Death Dis."},{"key":"B104","doi-asserted-by":"publisher","first-page":"1","DOI":"10.20517\/cdr.2024.84","article-title":"Intercellular transfer of multidrug resistance mediated by extracellular vesicles","author":"Yang","year":"2024","journal-title":"Cancer Drug Resist"},{"key":"B105","doi-asserted-by":"publisher","first-page":"1793","DOI":"10.3390\/biomedicines10081793","article-title":"Differential effects of D9 tetrahydrocannabinol (THC)- and cannabidiol (CBD)-based cannabinoid treatments on macrophage immune function in vitro and on gastrointestinal inflammation in a murine model","volume":"10","author":"Yekhtin","year":"2022","journal-title":"Biomedicines"},{"key":"B106","doi-asserted-by":"publisher","first-page":"1421","DOI":"10.17219\/acem\/181145","article-title":"Mechanisms of resistance to venetoclax in hematologic malignancies","volume":"33","author":"Zielonka","year":"2024","journal-title":"Adv. Clin. Exp. Med."}],"container-title":["Frontiers in Pharmacology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2026.1921501\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T08:11:33Z","timestamp":1790323893000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2026.1921501\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,25]]},"references-count":107,"alternative-id":["10.3389\/fphar.2026.1921501"],"URL":"https:\/\/doi.org\/10.3389\/fphar.2026.1921501","relation":{},"ISSN":["1663-9812"],"issn-type":[{"value":"1663-9812","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,25]]},"article-number":"1921501"}}